Pre-clinical study of amcenestrant and HER2-targeted therapies in HER2+/ER+ breast cancer cell line models

被引：1
|
作者：
Mahdi, Amira F.
Ashfield, Niall
Conlon, Neil T.
Crown, John
Collins, Denis M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-07-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-07-16
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer
    Bahnassy, Shaymaa
    Stires, Hillary
    Jin, Lu
    Tam, Stanley
    Mobin, Dua
    Balachandran, Manasi
    Podar, Mircea
    Mccoy, Matthew D.
    Beckman, Robert A.
    Riggins, Rebecca B.
    ENDOCRINOLOGY, 2023, 164 (12) : 1 - 15
  • [32] Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer
    Susan F. Dent
    Amber Morse
    Sarah Burnette
    Avirup Guha
    Heather Moore
    Current Oncology Reports, 2021, 23
  • [33] Targeting GPCR signaling in HER2+breast cancer suppresses cancer stem cell tumorigenicity and sensitizes HER2-targeted therapies
    Wang, Wei
    Bhargava, Dharmendra
    Ye, Yuan Chao
    Chen, Songhai
    CANCER RESEARCH, 2019, 79 (13)
  • [34] HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
    Xu, Luying
    Xie, Yuxin
    Gou, Qiheng
    Cai, Rui
    Bao, Rong
    Huang, Yucheng
    Tang, Ruisi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Treatment of ER+/HER2+breast cancer
    Johnston, Stephen
    CANCER RESEARCH, 2023, 83 (05)
  • [36] TILs in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Viale, G.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [37] Dual HER2-targeted approaches in HER2-positive breast cancer
    Eugene R. Ahn
    Charles L. Vogel
    Breast Cancer Research and Treatment, 2012, 131 : 371 - 383
  • [38] Impact of HER2-targeted therapy on overall survival (OS) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (MBC).
    Berghoff, A.
    Bartsch, R.
    Bago-Horvath, Z.
    Dubsky, P. C.
    Rudas, M.
    Pluschnig, U.
    Wiltschke, C.
    Gnant, M.
    Steger, G. G.
    Zielinski, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] Dual HER2-targeted approaches in HER2-positive breast cancer
    Ahn, Eugene R.
    Vogel, Charles L.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 371 - 383
  • [40] Her2-targeted therapies in non-small cell lung cancer
    Swanton, Charles
    Futreal, Andy
    Eisen, Tim
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4377S - 4383S
12345